Callan JMB (NASDAQ:CJMB – Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.59) earnings per share for the quarter, Zacks reports. Callan JMB had a negative net margin of 139.14% and a negative return on equity of 166.44%. The company had revenue of $1.11 million for the quarter.
Callan JMB Stock Up 1.0%
Shares of Callan JMB stock opened at $1.01 on Friday. Callan JMB has a 52 week low of $0.86 and a 52 week high of $5.88. The company has a market capitalization of $5.69 million, a PE ratio of -0.49 and a beta of 0.35. The stock’s fifty day moving average is $1.37 and its two-hundred day moving average is $1.93.
Wall Street Analysts Forecast Growth
Several research analysts have commented on CJMB shares. Wall Street Zen raised shares of Callan JMB to a “hold” rating in a research note on Saturday, March 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Callan JMB in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Insider Buying and Selling at Callan JMB
In other news, insider David J. Croyle bought 14,805 shares of the stock in a transaction on Friday, March 6th. The stock was acquired at an average cost of $1.76 per share, for a total transaction of $26,056.80. Following the acquisition, the insider owned 789,805 shares of the company’s stock, valued at $1,390,056.80. This represents a 1.91% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 73.87% of the company’s stock.
Institutional Investors Weigh In On Callan JMB
A hedge fund recently raised its stake in Callan JMB stock. Creative Planning grew its position in Callan JMB Inc. (NASDAQ:CJMB – Free Report) by 41.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 170,008 shares of the company’s stock after buying an additional 50,000 shares during the quarter. Creative Planning owned 3.79% of Callan JMB worth $830,000 at the end of the most recent reporting period.
About Callan JMB
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
Featured Articles
- Five stocks we like better than Callan JMB
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.
